Synced Nov 12 11:45 ET PHPreHealth
Agency workspace

Pulse

conexeu.com

Conexeu Sciences Inc. · Nasdaq: CNXU · Thermosensitive flowable collagen scaffold (Ten-Minute Tissue). Last 30 days to Nov 12, compared with the 30 days before. 510(k) premarket notification, lead wound-care candidate: Planned Q1 2027

Last 30 days at a glance

Every number is computed from today’s public snapshots. Hover for the formula, click for the detail.

Signal

Headlines per week, 12 weeks. Conexeu’s busiest week was Oct 16 (5). Click any week to see what ran.

ConexeuIntegra LifeSciencesGaldermaCollPlantEvolus
Weekly headlines: Conexeu and the four most-covered competitors
0102030
Aug 21Sep 18Oct 9This week

What changed

Computed from this month’s snapshots. Each line links to its evidence.

  • Conexeu Sciences had 13 headlines in 30 days (2 the month before). Most visible: “Top Conexeu Sciences (CNXU) Competitors 2026”.MarketBeat, Nov 11
  • Establishment Labs added the most coverage among competitors: 27 headlines, up from 6. Lead story: “Establishment Labs Stock Gets A Lift From Raised Revenue Outlook”.Yahoo Finance, Nov 12
  • Breast reconstruction beyond implants is the busiest category topic: 24 headlines in 3 weeks, 1.5× its earlier pace. Angle open to us: Regenerate, don't replace.SurvivorNet, Nov 11
  • The site crawl found 27 passages on conexeu.com to review against the claims rules, across 62 pages.Compliance
  • FDA cleared Accelagen Advanced Surgical Collagen Matrix, 1cc (CG-01AA); Accelagen Advanced Surgical Collagen Matrix, 2cc (CG-02AA); Accelagen Advanced Surgical Collagen Matrix, 3cc (CG-03AA); Accelagen Advanced Surgical Collagen Matrix, 5cc (CG-05AA); Accelagen Advanced Surgical Collagen Strip, 125x25x2mm (CG-125X25AA); Accelagen Advanced Surgical Collagen Strip, 250x25x2mm (CG-250X25AA) (Berkeley Advanced Biomaterials) on Oct 22, a comparable collagen/flowable wound device.K260920

Latest on Conexeu

Newest headlines naming the company or CXU.

All

Category topics

The conversations Conexeu Sciences can join without a product claim, ranked by headlines in the last 3 weeks.

Coverage